The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - a case finding study by Sandelowsky, Hanna et al.
RESEARCH ARTICLE Open Access
The prevalence of undiagnosed chronic
obstructive pulmonary disease in a primary care
population with respiratory tract infections - a
case finding study
Hanna Sandelowsky
1,2*, Björn Ställberg
3, Anna Nager
1 and Jan Hasselström
1
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is an underdiagnosed cause of morbidity and
mortality worldwide. Prevalence of COPD has been shown to be highly associated with positive smoking history
and increasing age. Spirometry is the method used for diagnosing COPD. However, identifying patients at risk of
COPD to undergo spirometry tests has been challenging. Therefore, there is a need for new cost-effective and
feasible diagnostic screening procedures for use in primary care centers. Our aim was to describe the prevalence
and severity of undiagnosed COPD in a group of patients with respiratory infections attending urgent primary care,
and to identify those variables in patients’ history that could be used to detect the disease.
Methods: Patients of 40-75 years (n = 138) attending urgent primary care center with acute respiratory tract
infection, positive smoking history and no previously known pulmonary disease underwent pre- and post
bronchodilator spirometry testing four to five weeks after the acute infection. Prevalence and severity of COPD were
estimated following the Global Initiative for COPD (GOLD) criteria. Variables such as sex, age, current smoking status,
smoking intensity (pack years) and type of infection diagnosis were assessed for possible associations with COPD.
Results: The prevalence of previously undiagnosed COPD in our study group was 27%, of which 45% were in
stage 1 (FEV1 ≥ 80% of predicted), 53% in stage 2 (50 ≤ FEV1 < 80% of predicted), 3% in stage 3 (30 ≤ FEV1 <
50% of predicted) and 0% in stage 4 (FEV1 < 30% of predicted). We found a significant association between COPD
and age ≥ 55 (OR = 10.9 [95% CI 3.8-30.1]) and between COPD and smoking intensity (pack years > 20) (OR = 3.2
[95% CI 1.2-8.5]). Sex, current smoking status and type of infection diagnosis were not shown to be significantly
associated with COPD.
Conclusion: A middle-aged or older patient with any type of common respiratory tract infection, positive smoking
history and no previously known pulmonary disease has an increased likelihood of having underlying COPD. These
patients should be offered spirometry testing for diagnosis of COPD.
Background
Chronic obstructive pulmonary disease (COPD) is an
underdiagnosed cause of morbidity and mortality world-
wide [1], with an estimated prevalence of 3-12% [2-4].
COPD causes suffering and adds substantial burden to
national healthcare budgets [5]. An early diagnosis may
motivate smoking cessation which is the only measure
known to radically improve future prospects for the
patient [6].
The prevalence of COPD increases considerably with
age and intensity of smoking, and can vary from 25% in
a general smoking population to approximately 50% in
the elderly smoking population [4,7-9]. Most subjects
with undiagnosed COPD have a mild form of the dis-
ease. Underdiagnosis most frequently involves patients
at early stages of COPD; approximately 95% of those in
* Correspondence: hanna.sandelowsky@sll.se
1Center for Family and Community Medicine (CeFAM), Department of
Neurobiology, Care Sciences and Society, Karolinska Institutet, Alfred Nobels
Allé 12, S-14183 Huddinge, Sweden
Full list of author information is available at the end of the article
Sandelowsky et al. BMC Family Practice 2011, 12:122
http://www.biomedcentral.com/1471-2296/12/122
© 2011 Sandelowsky et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.stage 1 (mild COPD) and 80% of those in stage 2 (mod-
erate COPD) remain undiagnosed [10].
Spirometry is the basis for diagnosis [11]. However,
primary care providers, who often meet patients with
respiratory symptoms, do not always have access, time
or adequate training to use this method [12]. Alterna-
tively, symptom-based questionnaires are available to
enhance COPD screening in primary care [13,14], but
are often considered time-consuming in a typical urgent
care setting. To identify patients at risk of COPD and
test them using spirometry has been challenging [15].
For all the reasons mentioned above, easy diagnostic
screening procedures that are feasible in primary care
settings are much needed [16,17]
Due to histopathological and immunological changes
in their respiratory tract, smokers are more susceptible
to prolonged complicated infections [18]. There is
increasing evidence implicating viral infections of the
respiratory tract to exacerbation of COPD. Thus, symp-
toms of both upper and lower respiratory tract infection
may in fact be signs of underlying COPD [19-22]. There
is a need for more studies into new methods for early
detection of COPD. At the same time, different ways of
“case finding” have been discussed [17,23]. Symptoms of
an underlying chronic lung disease may become obvious
when a patient develops an acute respiratory tract infec-
tion, since patients often become habituated to their
symptoms and do not report them to their physicians
during consultations [24]. In light of this, spirometry
testing on smokers with respiratory tract infections
could constitute a targeted approach to screening for
underlying COPD and was assessed here for the first
time.
We conducted a cross-sectional study whose aim was to
measure the prevalence and severity of undiagnosed
COPD among urgent care patients with respiratory tract
infections who had a positive smoking history but no prior
pulmonary disease diagnosis. An additional aim for this
study was to explore whether simple variables in a
patient’s history coupled with the respiratory infection
could be indicative of COPD.
Methods
Patients were invited to participate in the study between
January-March 2005 when they sought medical attention
due to respiratory tract infections. All patients had visited
either a primary health care center or an urgent primary
care unit in a suburban area of Stockholm, Sweden.
Patients, aged 40-75 years, who were eligible and agreed
to participate were either current smokers (or smoking-
free for no more than 6 months), or ex-smokers who had
come to an urgent primary care unit because they had
experienced symptoms of respiratory infection and had
received subsequent diagnosis (Table 1). Patients with
poor knowledge of Swedish, severe cardiac, psychiatric or
multi-organ disease, prior history of lung disease (except
for asthma) and those on medication with beta-blockers
were excluded. A consecutive sample of patients with an
ICD-10 diagnosis for respiratory tract infections was then
extracted from the medical records. The diagnoses were
subsequently validated by reviewing the medical records.
Patients who fit the inclusion criteria were contacted by
telephone. Telephone conversations were complemented
with formal written invitations sent by post together with
information about the study. According to the enrolment
plan (Figure 1), which had been approved by the Regional
Board of Ethics in Stockholm, Sweden, informed verbal
consent was obtained both by telephone and prior to
spirometry testing. Spirometry was performed four to
five weeks after patients were diagnosed with acute
respiratory infection, when respiratory function was no
longer considered to be affected by the infection [25].
Participants were also asked to provide information
about their smoking intensity ("pack years”,t a b l e2 ) .A n
“office desk” spirometer (Vitalograph Alpha spirometry)
that was calibrated daily according to manufacturer’s
instructions was used. A reference equation by the Eur-
opean Community for Coal and Steel (ECCS) was chosen
for reference values [26]. All patients showing airway lim-
itations (FEV1/FVC < 0.7) on the baseline test were given
a beta-2 agonist - 8 micrograms of formoterol via inhaler
(Oxis
® Turbuhaler
®). Post-bronchodilator spirometry
was performed after 15 minutes. The COPD diagnosis
Table 1 Infection diagnoses according to ICD-10
Upper respiratory tract
infection
J00-J06 Acute infections in the upper respiratory system (nasopharyngitis, sinusitis, pharyngitis, tonsillitis, laryngitis,
obstructive laryngitis, acute upper respiratory infection NOS)
Lower respiratory tract
infection
J11-J18 Pneumonia
J20-J22 Other acute lower respiratory infections (bronchitis, bronchiolitis, acute lower respiratory infection NOS)
R05 Cough*
Viral infection or
influenza
B34 Viral infection, unspecified
J10 Influenza
* Patients having predominantly symptoms of lower respiratory tract infection but receiving diagnosis code R05.
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Obstructive Lung Disease (GOLD) criteria [11]. Patients
who needed further medical attention were referred to
their family physicians.
Statistical analysis
The statistical analysis was performed using STATA,
version 8 [27]. Summary statistics such as means, pro-
portions and measures of dispersion were computed
using standard parametric methods. Multiple logistic
regression was used to analyze variables associated with
a COPD diagnosis, which also provided odds ratios and
their 95% confidence intervals (CI). P-values < 0.05 were
indicative of statistical significance. We chose the recei-
ver/response operating characteristic (ROC) curve to
select the most optimal prediction method, or model,
for variables associated with COPD, and to discard sub-
optimal ones independently from class distribution.
Notice about the study posted 
at sites, written/oral 
information to patient 
Did not meet inclusion 
criteria: 
1 patient 
Rejected spirometry: 
11 patients 
Consecutive sample of 
patients by retrospective 
review of journals. 
250 telephone contacts  
Spirometry, complementary 
information on smoking 
history: 
150 patients 
Invitations/information mailed: 
190 patients 
Did not meet criteria for 
smoking history: 
52 patients 
Did not want to 
participate: 
8 patients 
Failed to come to 
spirometry: 
40 patients 
Final patient sample: 
138 patients 
Figure 1 Study enrolment summary.
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Page 3 of 9In order to show how well the model discriminated data
we used standardized values describing the area under
the ROC-curve (excellent = 0.90-1, good = 0.80-.0.90,
fair = 0.70-0.80, poor = 0.60-0.70 and fail = 0.50-0.60).
When plotting the curve, the closer the ROC curve is to
the upper left corner, the higher the overall accuracy of
the test [28]. Confidence intervals according to classifi-
cation table were based on Wilson score method. P-
values < 0.05 were indicative of statistical significance.
In order to find a reasonable sample size, we chose
t h ep r e v a l e n c eo f3 0 % ,b a s e do np r e v i o u ss t u d i e st h a t
resembled ours in design [9,13]. A random sample of
140 patients would have given a 95% confidence interval
of ± 7% which was estimated to give a reasonable spread
to meet the aims of the study.
Ethical approval
The project was approved by the Regional Board of
Ethics in Stockholm, Sweden.
Results
Of the 138 eligible patients in urgent primary care, 38
were diagnosed with COPD, which corresponds to a
prevalence of 27% (95% CI ± 7%). Prevalence among
patients aged 55-75 years was 43%, whereas 8% was esti-
mated for patients in the younger age group (p < 0.001)
(table 2). There were as many men as women diagnosed
with COPD in the study group, though women were
significantly younger than men (mean age 59 versus 64
years), (p = 0.023). Two thirds of all COPD cases were
current smokers, the majority of them women (p =
0.087). Thirty-four per cent of current smokers and 20%
of ex-smokers had COPD (p = 0.061). The average
number of pack years among patients with COPD was
32. There was no significant difference in the distribu-
tion of upper respiratory tract infection (URTI) and
lower respiratory tract infection (LRTI) between the
COPD and non-COPD groups, while COPD was nearly
equally distributed in URTI and LRTI groups.
Table 2 Description of 138 patients with respiratory tract infections seeking urgent primary care
Variables Total COPD Non-COPD
N (%) 138 38 (27) 100 (73)
Age
Years, mean [95%CI] 55 [54-57] 62 [59-64] 53 [51-55]
Agegroup 40-54 years n (%) 62 5 (13) 57 (57)
Agegroup 55-70 years n (%) 76 33 (87) 43 (43)
Smoking intensity
Pack years*, mean [95%CI] 24 [22-26] 32 [27-36] 21 [19-24]
Pack years*, median [range] 20 [5-75] 31 [5-75] 20 [5-56]
Smoking status
Current smokers, n (%) 73 25 (65.8) 48 (48.0)
Former smokers, n (%) 65 13 (34.2) 52 (52.0)
Diagnosis
Upper resp. infection, n (%) 57 15 (39.5) 42 (42.0)
Lower resp. infection, n (%) 79 23 (60.5) 56 (56.0)
Viral infection/influenza, n (%) 2 0 (0) 2 (2.0)
Sex
Female, n (%) 19 (50) 58 (58)
Male 19 (50) 42 (42)
Spirometry
FEV1% of predicted, mean [95%CI] 95.7 [92.6-98.8] 77.5 [71.2-84.0] 102.6 [100.2-105.1]
FEV1/FVC ratio, mean [95%CI] 0.73 [0.71-0.75] 0.60 [0.57-0.63] 0.78 [0.77-0.79]
COPD severity** N %
Stage 1 (mild, FEV1 ≥ 80% of predicted) 17 (44.7)
Stage 2 (moderate, 50% ≤ FEV1 < 80% of predicted) 20 (52.6)
Stage 3 (severe, 30% ≤ FEV1 < 50% of predicted) 1 (2.6)
Stage 4 (very severe, FEV1 < 30% of predicted) 0 (0)
Numbers in total and divided into groups with or without COPD.
*Number of pack years = (number of cigarettes smoked per day × number of years smoked/20)
** According to Global Initiative for Chronic Obstructive Lung Disease (GOLD)
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Page 4 of 9Specifically, 26% of patients with URTI also had COPD,
of which 47% were in stage 1 and 53% in stage 2 (none
in stage 3). Similarly, 29% of patients with LRTI also
had COPD, of which 44% were in stage 1, 52% in stage
2 and 4% in stage 3.
Figure 2 shows the spirometry results of all 138
patients, plotted as FEV1 in relation to FEV1/FVC. For
COPD patients, the mean FEV1/FVC was 0.60 (min
0.43, max 0.69) and the mean FEV1 was 77.5% (min
41%, max 113%) of the predicted value. Spirometry
results, including severity grades of COPD and a sum-
mary of the data are shown in table 2. Lung function
values were evenly distributed across all ages (Figure 3).
Multiple logistic regression analysis, using COPD as a
response variable, revealed a statistically significant asso-
ciation between COPD and age ≥ 55 years (OR = 10.9
[95% CI 3.8-30.1], p < 0.001) and between COPD and
pack years ≥ 20 (OR = 3.2 [95% CI 1.2-8.5], p = 0.016),
after adjustments for all explanatory variables were
made (Table 3). Neither current smoking (OR = 2.5
[95% CI 0.9-6.6], p = 0.071) nor sex or location of infec-
tion diagnosis (URTI or LRTI) were significantly asso-
ciated with COPD. Based on the observations above, a
model for predicting COPD was created. The model
included positive variables “age ≥ 55”, “pack years ≥ 20”
and “current smoker as positive predictors for COPD
and showed a sensitivity and a specificity of 45% [95%
CI 30-60%], and of 89% [95% CI 81-94%], respectively.
The positive and negative predictive values were 61%
[95% CI 42-76%], and 81% [95% CI 73-87%], respec-
tively. Although variable “current smoker” did not show
a significant association with COPD, it was used as a
confounder since it caused the odds ratios of the top
variables (age, pack years) to vary by more than 10%.
The area under the receiver/response operating charac-
teristic (ROC) curve was 0.83 (Figure 4). Finally, the
proportion of correctly classified observations (COPD or
non-COPD) was 77%.
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Figure 2 Results of spirometry in 138 patients seeking urgent primary care for respiratory infections.
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Page 5 of 9Nineteen percent (n = 40) of patients who were
invited to undergo spirometry failed to show for their
appointments. The dropout rate was independent of sex,
age and infection diagnosis. However, smoking status
(current or ex-smoker) and intensity (pack years) of
patients who dropped out were not recorded.
Discussion
There is an ongoing discussion about how to improve
early detection of COPD. In this case finding study we
found a high prevalence (27%) of previously undiag-
nosed COPD. Statistical analysis showed that assessing
three simple variables (age, smoking intensity and
Figure 3 Correlation of FEV1 (% predicted) and age (years) for all participants with COPD.
Table 3 The odds ratio (OR) for having COPD
COPD
Age Years ≥ 55 10.9 [3.8-30.1]
< 55 1.0
Smoking intensity Pack years ≥ 20 3.2 [1.2-8.5]
< 20 1.0
Smoking status Current smoker yes 2.5 [0.9-6.6]
no 1.0
Diagnosis Upper respiratory infection 0.8 [0.3-2.0]
Lower respiratory infection 1.0
Sex female 0.9 [0.3-2.1]
male 1.0
Odds ratios adjusted for pack years, age, current smoking status, diagnosis and sex with 95% confidence intervals.
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Page 6 of 9smoking status) among patients with any kinds of acute
respiratory infections attending urgent primary care
c o u l db eaf e a s i b l ea n de f f e c t i v ew a yt os h o r t - l i s tt h o s e
who need spirometry testing to confirm the presence of
underlying COPD. Moreover, preliminary screening for
airflow obstruction using a handheld spirometer prior to
full spirometry testing may be an efficient way of finding
new COPD cases [29].
In comparison with other case finding methods, such
as questionnaires and random screenings of smokers this
study utilized a targeted approach in a real-life context
[9,13,23,30]. In addition, such an approach would be sui-
table in urgent care settings, where consultation time is
usually limited. Questionnaires may be more appropriate
in clinical settings other than urgent primary care where
more time for consultation is available.
The distribution patterns of different stages of COPD
matched previous prevalence estimates [7,9,10] and indi-
cated early COPD. The distribution of stage 1 was found
to be independent of age ruling out the possibility of
overdiagnosis among the elderly persons in this study
population. Instead, 53% of undiagnosed COPD cases
were in stage 2 (moderate) and 45% in stage 1 (mild) sug-
gesting not only that underdiagnosis of COPD may be
common but also that underdiagnosis of moderately
advanced stages of COPD may be common. In effect,
underdiagnosis has been shown in earlier epidemiological
studies of COPD among primary care patients [9,11,31].
These studies have shown that underdiagnosis of COPD
occured partly because of “doctor’sd e l a y ”, i.e., doctors
who don’t suspect underlying COPD [32,33] and partly
because of “patient’s delay”,i . e ,p a t i e n t sw h os e l f - r e p o r t
good health [34].
The major strength of the study is its connection and
relevance to real-life contexts in primary health care. Our
case finding approach suggests that both patients and doc-
tors play an active role in the early detection of COPD
which, in turn, may lead to new diagnoses and patients
with increased motivation to quit smoking [35].
To our knowledge, no case finding study has been per-
formed in a study group similar to ours. A high prevalence
of COPD among patients with LRTI and positive smoking
history has been shown earlier [31]. Interestingly, a fourth
of patients with URTI in our study had a previously
undiagnosed COPD and prevalence among all patients
was independent of the infection site, i.e, upper or lower
respiratory tract. However, due to the small sample size,
conclusions should be drawn with caution. More studies
on the role of the infection site in the detection of COPD
are needed. Prevalence of COPD in our study population
was consistent with that observed in earlier studies
[9,11,31]. Prevalence of undiagnosed COPD among smo-
kers is largely known to be approximately 20-50% depend-
ing on smoker’s age and smoking intensity [8].
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Figure 4 Receiver/response operating characteristic (ROC) curve adjusted for age, pack years, current smoking, sex and infection
diagnosis.
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Page 7 of 9Although the women with undiagnosed COPD in the
group were younger than the men, we found no associa-
tion between prevalence of COPD and sex. This finding
was inconsistent with earlier studies, though the small
sample size may explain the discrepancy. Recent evidence
has suggested that women are at higher risk of develop-
ing COPD than men accompanied by an earlier onset
and a more severe clinical manifestation of the disease
[36,37]. Prevalence of COPD among women is likely to
increase due to changes in smoking habits of women
[38].
The positive (61%) and negative (81%) predictive values
of our model, which utilized three variables (age, smok-
ing status and intensity) to detect COPD in patients with
an acute respiratory tract infection were relatively high.
A possible explanation for this outcome may be that mul-
tiple regression analysis was influenced by the presence
of random factors typical for small-sample studies.
Having said that, the small sample size was the main
limitation of this study. In addition, the exclusion of
patients aged 75 years or over and patients with severe
cardiac disease and severe psychiatric diagnoses, among
whom prevalence of COPD has been shown to be high
[39], is another notable limitation of this study. The rea-
son for excluding those patient groups was the particular
focus of this study on patients who do not normally
attend primary care. As a consequence, we may have
observed a lower prevalence of COPD than that reported
in studies with broader inclusion criteria [14,40]. Also,
although we were aware that the optimum time for per-
forming spirometry on patients with COPD was six to
seven weeks after an exacerbation [41], we chose to per-
form the test on our study population four to five weeks
after infection onset since we had no prior knowledge of
who had underlying COPD.
Conclusion
COPD is a potentially life-threatening disease whose
progress can be slowed relatively easily and inexpen-
sively by smoking cessation. We conclude that patients
aged 40 or over with a positive smoking history (more
than 20 pack years) who develop any type of respiratory
infection may also have underlying COPD. Thus, it is
crucial for physicians to identify this high-risk group
and offer them spirometry testing for early detection of
COPD, which may motivate those patients to quit
smoking.
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